Company page

Fusion Antibodies Plc

Fusion Antibodies Plc, trading under the ticker FAB, is a public company listed in the UK with a market capitalization of approximately £19.83 million. The company specializes in providing antibody engineering services and solutions. Fusion Antibodies focuses on advancing therapeutic antibody development for its clients in the biopharmaceutical sector.